WallStreetZenWallStreetZen

Stock IdeasStrong Buy Stocks
Strong Buy Stocks from Top Wall Street Analysts
Latest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen

Analyst / FirmCompanyPriceRatingPrice TargetUpside/DownsideDate
Richard Newitter
Truist Securities
Top 9%
92
Carlsmed IncCARL
$18.60Strong Buy$23.00+23.66%
a day ago
Analyst Ranking
Top 9%
#467 out of 5557 analysts
Average Return
+7.01%
Win Rate
47%150 out of 318
Risk vs Reward
Poor
Good

Analyst Color

Truist Securities's Richard Newitter raised their price target on Carlsmed (NASDAQ: CARL) by 15% from $20 to $23 on 2026/11/11. The analyst maintained their Strong Buy rating on the stock.

Carlsmed reported its Q3 2026 earnings.

Raising their price target, Newitter noted the quarter's revenue and EBITDA beats, and detailed:

  • 76% procedure growth across a growing surgeon base.
  • The company's cervical business reached 12% of overall revenue and continues to ramp above plan.
Philippe Houchois
Jefferies
Top 19%
82
Tesla IncTSLA
$800.00Strong Buy$850.00+6.25%
a day ago

Upgrade to Premium to View More

Strong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts

Already have access to Premium? Sign In
12345...942
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.